US SB3021 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 11 2019 - 25% progression, died in committee
Action: 2019-12-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 11 2019 - 25% progression, died in committee
Action: 2019-12-11 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
Title
Gluten in Medicine Disclosure Act of 2019
Sponsors
| Sen. Richard Blumenthal [D-CT] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-12-11 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB2074 (Same As) 2019-04-04 - Referred to the Subcommittee on Health.
Subjects
Consumer affairs
Drug safety, medical device, and laboratory regulation
Grain
Health
Nutrition and diet
Prescription drugs
Drug safety, medical device, and laboratory regulation
Grain
Health
Nutrition and diet
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/3021/all-info |
| Text | https://www.congress.gov/116/bills/s3021/BILLS-116s3021is.pdf |
